OppenheimerFunds Inc. boosted its position in Waters Corporation (NYSE:WAT) by 2.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,750 shares of the medical instruments supplier’s stock after buying an additional 35 shares during the period. OppenheimerFunds Inc.’s holdings in Waters Corporation were worth $274,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in WAT. Creative Planning raised its stake in Waters Corporation by 1.6% in the first quarter. Creative Planning now owns 744 shares of the medical instruments supplier’s stock worth $116,000 after buying an additional 12 shares during the last quarter. Quadrant Capital Group LLC raised its stake in Waters Corporation by 4.4% in the first quarter. Quadrant Capital Group LLC now owns 822 shares of the medical instruments supplier’s stock worth $124,000 after buying an additional 35 shares during the last quarter. Advisory Services Network LLC purchased a new stake in Waters Corporation during the first quarter worth $169,000. Van ECK Associates Corp raised its stake in Waters Corporation by 7.4% in the first quarter. Van ECK Associates Corp now owns 1,129 shares of the medical instruments supplier’s stock worth $176,000 after buying an additional 78 shares during the last quarter. Finally, Diversified Trust Co purchased a new stake in Waters Corporation during the first quarter worth $200,000. Hedge funds and other institutional investors own 92.06% of the company’s stock.
Shares of Waters Corporation (WAT) traded down 0.29% during trading on Friday, hitting $179.70. 333,163 shares of the stock were exchanged. Waters Corporation has a one year low of $133.35 and a one year high of $187.65. The stock has a market cap of $14.34 billion, a PE ratio of 27.08 and a beta of 0.84. The stock’s 50 day moving average price is $179.86 and its 200 day moving average price is $168.91.
Waters Corporation (NYSE:WAT) last issued its quarterly earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.71 by $0.05. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The business had revenue of $558.30 million during the quarter, compared to the consensus estimate of $553.22 million. During the same period in the previous year, the business earned $1.58 EPS. The business’s quarterly revenue was up 4.0% on a year-over-year basis. Equities research analysts predict that Waters Corporation will post $7.38 EPS for the current year.
Waters Corporation declared that its board has initiated a stock buyback program on Thursday, May 11th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the medical instruments supplier to buy up to 7.3% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board believes its stock is undervalued.
COPYRIGHT VIOLATION NOTICE: This story was originally reported by BNB Daily and is the sole property of of BNB Daily. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.baseball-news-blog.com/2017/08/19/oppenheimerfunds-inc-has-274000-position-in-waters-corporation-nysewat-updated-updated-updated.html.
A number of analysts recently weighed in on the stock. BidaskClub upgraded shares of Waters Corporation from a “buy” rating to a “strong-buy” rating in a research note on Wednesday. Wells Fargo & Company restated an “outperform” rating and set a $205.00 target price (up from $195.00) on shares of Waters Corporation in a research note on Thursday, July 13th. Barclays PLC set a $160.00 target price on shares of Waters Corporation and gave the stock a “hold” rating in a research note on Wednesday, April 26th. Zacks Investment Research upgraded shares of Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 target price on the stock in a research note on Thursday, July 13th. Finally, Jefferies Group LLC restated a “hold” rating and set a $175.00 target price on shares of Waters Corporation in a research note on Thursday, July 27th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Waters Corporation presently has a consensus rating of “Hold” and a consensus price target of $186.00.
In other news, Director Christopher A. Kuebler sold 3,500 shares of the business’s stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total value of $628,845.00. Following the completion of the sale, the director now directly owns 17,849 shares in the company, valued at approximately $3,206,929.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Rohit Khanna sold 23,000 shares of the business’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $186.90, for a total value of $4,298,700.00. Following the completion of the sale, the senior vice president now owns 27,077 shares of the company’s stock, valued at $5,060,691.30. The disclosure for this sale can be found here. Insiders sold a total of 59,780 shares of company stock valued at $10,914,011 over the last quarter. Company insiders own 5.07% of the company’s stock.
About Waters Corporation
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.